Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
FBLG
#3765
FibroBiologics, Inc. Common Stock
0.3
3
+17.86%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+17.86%
Variazione Mensile
-8.33%
Variazione di 6 mesi
-45.90%
Variazione Annuale
-72.73%
Chiusura Precedente
0.2
8
Open
0.3
3
Bid
Ask
Low
0.3
3
High
0.3
3
Volume
3
Mercati
Mercato Azionario Statunitense
Salute
FBLG
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.92 M
35.09 M
37.74 M
40.86 M
48.26 M
66.52 M
193.38 M
Valuation ratios
Enterprise value
99.27 M
70.95 M
25.77 M
17.26 M
23.21 M
10.31 M
76.55 M
Price to earnings ratio
-5.24
-5.88
-4.29
-1.73
-1.14
-0.54
-7.69
Price to sales ratio
—
71.47
—
—
4.73
2.95
—
Price to cash flow ratio
9.33
5.52
2.4
1.49
1.26
0.61
5.77
Price to book ratio
9.56
24.04
2.98
2.48
3.17
1.63
10.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.08
0.43
0.33
0.66
0.34
1.77
Return on equity %
0.18
0.48
2.11
5.42
46.22
0.53
54.28
Return on invested capital %
—
—
—
—
—
-403.37
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
403.37
287.87
244.29
-3 759.7
2 055.56
-1 171.99
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
141.63
315.5
253.43
-4 311.94
2 574.6
-1 168.41
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.23
1.12
1.14
0.93
0.78
3.61
6.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.11
0.15
-0.01
0.01
0.26
Solvency ratios
Debt to assets ratio
—
0.58
—
—
—
—
—
Debt to equity ratio
—
3.46
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.56
0.51
0.58
0.52
0
1.61
Long term debt to total equity ratio
0.04
3.35
2.48
9.38
36.58
0
48.45
Per share metrics
Operating cash flow per share
0.08
0.09
0.14
0.1
0.09
0.07
0.41
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
0.29
—
—
—
—
—
Cash per share
0.23
0.43
0.24
0.23
0.11
0.11
0.69
Net current asset value per share
0.24
0.43
0.25
0.26
0.12
0.14
0.78
Tangible book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
Working capital per share
0.05
0.05
0.03
-0.02
-0.03
0.1
0.08
Book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
Notizie
H.C. Wainwright riduce il target di prezzo di FibroBiologics a $4
H.C. Wainwright cuts FibroBiologics stock price target to $4
Gli azionisti di FibroBiologics approvano il raggruppamento azionario e l’emissione di warrant
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics ottiene proroga da Nasdaq per rispettare i requisiti di quotazione
FibroBiologics gets Nasdaq extension to meet listing rules
FibroBiologics inizierà la sperimentazione clinica per ulcere diabetiche nel 2026
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
FibroBiologics riporta risultati positivi per la terapia della degenerazione discale
FibroBiologics reports positive results for disc degeneration therapy
FibroBiologics riceve avviso di delisting dal Nasdaq, richiede udienza per fare appello
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal